Evidence map›Paper›PMID 29531223›Full record

ArticleNature communications2018

Vesicular glutamate release from central axons contributes to myelin damage.

Sean Doyle, Daniel Bloch Hansen, Jasmine Vella, Peter Bond, Glenn Harper, Christian Zammit, Mario Valentino, Robert Fern

Abstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Plasticity of Myelination.Advances in neurobiology · 2025
    Review
  8. Article
  9. Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sean DoyleUniversity of Plymouth, Plymouth, PL6 8BY, UK.
Daniel Bloch HansenUniversity of Plymouth, Plymouth, PL6 8BY, UK.
Jasmine VellaUniversity of Malta, Msida, MSF 2080, Malta.
Peter BondUniversity of Plymouth, Plymouth, PL6 8BY, UK.
Glenn HarperUniversity of Plymouth, Plymouth, PL6 8BY, UK.
Christian ZammitUniversity of Malta, Msida, MSF 2080, Malta.
Mario ValentinoUniversity of Malta, Msida, MSF 2080, Malta.
Robert FernUniversity of Plymouth, Plymouth, PL6 8BY, UK. Robert.fern@plymouth.ac.uk.ORCID http://orcid.org/0000-0002-0625-3434

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The axon myelin sheath is prone to injury associated with N-methyl-D-aspartate (NMDA)-type glutamate receptor activation but the source of glutamate in this context is unknown. Myelin damage results in permanent action potential loss and severe functional deficit in the white matter of the CNS, for example in ischemic stroke. Here, we show that in rats and mice, ischemic conditions trigger activation of myelinic NMDA receptors incorporating GluN2C/D subunits following release of axonal vesicular glutamate into the peri-axonal space under the myelin sheath. Glial sources of glutamate such as reverse transport did not contribute significantly to this phenomenon. We demonstrate selective myelin uptake and retention of a GluN2C/D NMDA receptor negative allosteric modulator that shields myelin from ischemic injury. The findings potentially support a rational approach toward a low-impact prophylactic therapy to protect patients at risk of stroke and other forms of excitotoxic injury.

Indexed as

AnimalsAxonsCytoplasmic VesiclesFemaleGlutamic AcidHumansIschemiaMaleMiceMice, Inbred C57BLMyelin SheathRatsRats, WistarReceptors, N-Methyl-D-AspartateGlutamic AcidNR2C NMDA receptorNR2D NMDA receptorReceptors, N-Methyl-D-Aspartate

Identifiers

PMID29531223
PMCPMC5847599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.